Senior Vice President, New Business Development, Corporate Strategy and Portfolio
Charlie Attlan is our senior vice president, New Business Development, Corporate Strategy and Portfolio, a position he has held since March 2010. In this role, he has oversight for corporate strategy, business development activity, mergers, acquisitions, divestitures, joint ventures licensing and distribution agreements, venture capital and minority investments. Prior to joining Boston Scientific, Charlie served as senior vice president, Credit Suisse (and its predecessor firm, Donaldson Lufkin & Jenrette), and in other roles of increasing responsibility, from 1999 until 2009, and an associate, and in other roles of increasing responsibility, at BT Alex Brown from 1993 until 1999. Charlie graduated magna cum laude, with a B.A. in Economics and Math, from Princeton University.